ID

21784

Description

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT00299104

Lien

https://clinicaltrials.gov/show/NCT00299104

Mots-clés

  1. 30/04/2017 30/04/2017 -
Téléchargé le

30 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Rheumatoid Arthritis NCT00299104

Eligibility Rheumatoid Arthritis NCT00299104

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients 18-80 years of age
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
ra for ≥ 2 months;
Description

Rheumatoid Arthritis: Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0872146
UMLS CUI [1,2]
C0003873
receiving outpatient treatment
Description

Outpatient

Type de données

boolean

Alias
UMLS CUI [1]
C0029921
patients naive to, and considered to be candidates for, methotrexate treatment
Description

Methotrexate Treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0746573
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
rheumatic autoimmune disease other than ra, or significant systemic involvement secondary to ra
Description

Rheumatic autoimmune disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C0035435
inflammatory joint disease other than ra, or other systemic autoimmune disorder
Description

Inflammatory joint disease or systemic autoimmune disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0683381
UMLS CUI [2]
C1384868
diagnosis of juvenile rheumatoid arthritis, or ra before the age of 16
Description

Juvenile rheumatoid arthritis or age of onset

Type de données

boolean

Alias
UMLS CUI [1]
C0311221
UMLS CUI [2]
C0206132
surgery within 12 weeks of study
Description

Surgery

Type de données

boolean

Alias
UMLS CUI [1]
C0543467
previous treatment with any approved or investigational biologic agent for ra, an anti-alpha4-integrin antibody or co-stimulation modulator, or cell-depleting therapy
Description

Prior treatment

Type de données

boolean

Alias
UMLS CUI [1]
C1514463
concurrent treatment with any biologic agent or dmard other than methotrexate
Description

Concurrent treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0013227

Similar models

Eligibility Rheumatoid Arthritis NCT00299104

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
adult patients 18-80 years of age
boolean
C0001779 (UMLS CUI [1])
Rheumatoid Arthritis: Duration
Item
ra for ≥ 2 months;
boolean
C0872146 (UMLS CUI [1,1])
C0003873 (UMLS CUI [1,2])
Outpatient
Item
receiving outpatient treatment
boolean
C0029921 (UMLS CUI [1])
Methotrexate Treatment
Item
patients naive to, and considered to be candidates for, methotrexate treatment
boolean
C0746573 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Rheumatic autoimmune disease
Item
rheumatic autoimmune disease other than ra, or significant systemic involvement secondary to ra
boolean
C0004364 (UMLS CUI [1,1])
C0035435 (UMLS CUI [1,2])
Inflammatory joint disease or systemic autoimmune disorder
Item
inflammatory joint disease other than ra, or other systemic autoimmune disorder
boolean
C0683381 (UMLS CUI [1])
C1384868 (UMLS CUI [2])
Juvenile rheumatoid arthritis or age of onset
Item
diagnosis of juvenile rheumatoid arthritis, or ra before the age of 16
boolean
C0311221 (UMLS CUI [1])
C0206132 (UMLS CUI [2])
Surgery
Item
surgery within 12 weeks of study
boolean
C0543467 (UMLS CUI [1])
Prior treatment
Item
previous treatment with any approved or investigational biologic agent for ra, an anti-alpha4-integrin antibody or co-stimulation modulator, or cell-depleting therapy
boolean
C1514463 (UMLS CUI [1])
Concurrent treatment
Item
concurrent treatment with any biologic agent or dmard other than methotrexate
boolean
C0013227 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial